Lore Schrutka

Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy

René Rettl, Christopher Mann, Franz Duca et al. · European Heart Journal - Cardiovascular Imaging · 2021 · 92 citations · Full text

Medicine, Cardiology, Neurology +16

Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology

Uwe Zeymer, Peter Ludman, Nicolas Danchin et al. · European Heart Journal · 2021 · 80 citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

Beneficial effects of levosimendan on survival in patients undergoing extracorporeal membrane oxygenation after cardiovascular surgery

Klaus Distelmaier, Christian Roth, Lore Schrutka et al. · British Journal of Anaesthesia · 2016 · 76 citations · Full text

Medicine, Perioperative Medicine, Surgery +9

Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery

Christian Roth, Lore Schrutka, Christina Binder et al. · Critical Care · 2016 · 69 citations · Full text

Medicine, Perioperative Medicine, Surgery +12

Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy

René Rettl, Tim Wollenweber, Franz Duca et al. · European Heart Journal - Cardiovascular Imaging · 2023 · 66 citations · Full text

Medicine, Cardiology, Nuclear Medicine +17